MEDTRADE RECEIVES EU MDR CERTIFICATION FOR THE CELOX CE RANGE
Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI.
The EU MDR is a medical device regulation that affects all medical devices placed in the European market.
Medtrade the parent company of Celox Medical has been working vigorously to make sure all existing medical devices’ technical documentation and processes are in accordance with the new regulations.
The Celox Medical team of highly skilled experts have a wealth of knowledge in materials science, regulatory, quality requirements and manufacturing processes, and use this to bring to market ground-breaking innovations, that rapidly, safely and effectively treat life-threatening bleeding in pre-hospital emergency situations.
Russ Mably, Medtrade CEO commented “We are delighted to receive our MDR certification for the Celox CE range of products. We look forward to continuing to provide our 20 years proven military-grade Celox product range which is designed to stop life-threatening emergency bleeding fast and help save lives.”
About Medtrade:
Medtrade Products Limited, a UK based medical device company established in 1999 with headquarters in Crewe, England provides products and services to the healthcare sector globally.
Medtrade is at the forefront of innovative medical device research and development. With experienced management and scientific leadership within the area s of Haemostasis, Advanced Wound Care and Infection Control, Medtrade designs and delivers pioneering innovative clinically effective products to address unmet clinical needs in pre-hospital and hospital settings.
For further information contact: info@medtrade.co.uk
